These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27848224)

  • 1. MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.
    Dua K; Hansbro NG; Foster PS; Hansbro PM
    Drug Deliv Transl Res; 2017 Feb; 7(1):168-178. PubMed ID: 27848224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.
    Awasthi R; Rathbone MJ; Hansbro PM; Bebawy M; Dua K
    Drug Deliv Transl Res; 2018 Feb; 8(1):97-110. PubMed ID: 29185148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
    Weirauch U; Gutsch D; Höbel S; Aigner A
    Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.
    Ebrahimi A; Sadroddiny E
    Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
    Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
    J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic targets for novel therapies of lung diseases.
    Comer BS; Ba M; Singer CA; Gerthoffer WT
    Pharmacol Ther; 2015 Mar; 147():91-110. PubMed ID: 25448041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of miRNAs as potential biomarkers in lung diseases.
    Alipoor SD; Adcock IM; Garssen J; Mortaz E; Varahram M; Mirsaeidi M; Velayati A
    Eur J Pharmacol; 2016 Nov; 791():395-404. PubMed ID: 27634639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases.
    Shi MA; Shi GP
    Sci Signal; 2010 Nov; 3(146):pe40. PubMed ID: 21045204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting microRNAs using nanotechnology in pulmonary diseases.
    Dua K; Chellappan DK; Singhvi G; de Jesus Andreoli Pinto T; Gupta G; Hansbro PM
    Panminerva Med; 2018 Dec; 60(4):230-231. PubMed ID: 30563304
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases.
    Hassan T; McKiernan PJ; McElvaney NG; Cryan SA; Greene CM
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):359-68. PubMed ID: 22397568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
    Calway T; Kim GH
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):131-43. PubMed ID: 25261390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
    Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
    Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges.
    Chakraborty C; Wen ZH; Agoramoorthy G; Lin CS
    Curr Drug Metab; 2016; 17(5):469-77. PubMed ID: 26813887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticles to Deliver miRNA in Cancer.
    Campani V; De Rosa G; Misso G; Zarone MR; Grimaldi A
    Curr Pharm Biotechnol; 2016; 17(8):741-9. PubMed ID: 27215371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.